New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2018, WHO recommendations Uterotonics for the prevention of postpartum haemorrhage
View latest version (2018)Bibliographic Info
GuidelineWHO recommendations for the prevention and treatment of postpartum haemorrhage
Year of Publication2012
Issuing InstitutionWorld Health Organization
Recommendation
Status
Retired
Recommended in favor
Strong
Certainty of evidence
Moderate
In settings where skilled birth attendants are not present and oxytocin is unavailable, the administration of misoprostol (600 µg PO) by community health care workers and lay health workers is recommended for the prevention of postpartum haemorrhage